MedTrace Logo

Predictors of Mortality in Patients With Autoimmune Diseases Admitted to the Intensive Care Unit

NCT04022655 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2019-07-24

No results posted yet for this study

Summary

Autoimmune diseases, such as systemic lupus erythematosus, rheumatoid arthritis, myositis, or anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, may affect multiple organ systems. Occasionally, patients deteriorate acutely requiring advanced care in an intensive care unit (ICU). In an ICU setting, mortality is estimated with scoring systems, such as APACHE or SAPSII. Since there are limited data available on their use in autoimmune diseases, with the current study, we aim to assess the usefulness of these ICU scores and analyze predictors of mortality in this particular group of patients.

Conditions

Interventions

OTHER

ICU Care

No intervention

Sponsors & Collaborators

  • University Medical Center Goettingen

    collaborator OTHER

  • University of Göttingen

    lead OTHER

Principal Investigators

  • Peter Korsten, MD · University Medical Center Göttingen

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-22
Primary Completion
2019-08-31
Completion
2019-10-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04022655 on ClinicalTrials.gov